SCHEMBL404580

SCHEMBL404580

CCOC(=O)c1sc(N)nc1-c1ncnn1CCOC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.52
HSD17B10 Q99714 3/20 0.52
FBP1 P09467 2/20 0.50
CYP1A2 P05177 1/20 0.47
HPGD P15428 4/20 0.44
GAA P10253 3/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39
XIAP P98170 1/20 0.39
PLEC Q15149 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CDC7 O00311 3/20 0.37
DBF4 Q9UBU7 3/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL401694 0.88 ALDH1A1 (0.57) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL404775 0.87 FBP1 (0.39) ALDH1A1HSD17B10FBP1HPGDGAA
SCHEMBL404561 0.84 ALDH1A1 (0.58) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL403810 0.82 ALDH1A1 (0.51) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL403488 0.80 ALDH1A1 (0.52) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL404952 0.75 ALDH1A1 (0.58) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL509688 0.74 ALDH1A1 (0.42) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL401914 0.74 ALDH1A1 (0.40) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL3406570 0.71 ALDH1A1 (0.57) ALDH1A1HSD17B10FBP1CYP1A2HPGD
SCHEMBL1505583 0.71 ALDH1A1 (0.67) ALDH1A1HSD17B10FBP1CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022107-A1 2-(PIPERIDIN-1-YL)-4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2012-01-26 US disclosed
US-20120022107-A1 2-(PIPERIDIN-1-YL)-4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2012-01-26 US disclosed
US-20120022107-A1 2-(PIPERIDIN-1-YL)-4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2012-01-26 US disclosed
EP-2379545-A1 2- (PIPERIDIN-1-YL) -4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS AstraZeneca AB (SE) 2011-10-26 EP disclosed
WO-2010067125-A1 2- (PIPERIDIN-1-YL) -4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2010-06-17 WO disclosed
WO-2010067125-A1 2- (PIPERIDIN-1-YL) -4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022107-A1 2-(PIPERIDIN-1-YL)-4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS PIR, TLR5, ALPI ALDH1A1 57/4885HSD17B10 3230/4885FBP1 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.